- Home
- CMPS vs MIN Comparison
CMPS vs MIN Comparison
Compare CMPS & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- MIN
- Stock Information
- Founded
- CMPS 2020
- MIN 1988
- Country
- CMPS United Kingdom
- MIN United States
- Employees
- CMPS N/A
- MIN N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- MIN Trusts Except Educational Religious and Charitable
- Sector
- CMPS Health Care
- MIN Finance
- Exchange
- CMPS Nasdaq
- MIN Nasdaq
- Market Cap
- CMPS 364.9M
- MIN 304.4M
- IPO Year
- CMPS 2020
- MIN N/A
- Fundamental
- Price
- CMPS $2.73
- MIN $2.67
- Analyst Decision
- CMPS Strong Buy
- MIN
- Analyst Count
- CMPS 7
- MIN 0
- Target Price
- CMPS $17.83
- MIN N/A
- AVG Volume (30 Days)
- CMPS 3.9M
- MIN 331.0K
- Earning Date
- CMPS 07-31-2025
- MIN 01-01-0001
- Dividend Yield
- CMPS N/A
- MIN 7.31%
- EPS Growth
- CMPS N/A
- MIN N/A
- EPS
- CMPS N/A
- MIN 0.08
- Revenue
- CMPS N/A
- MIN N/A
- Revenue This Year
- CMPS N/A
- MIN N/A
- Revenue Next Year
- CMPS N/A
- MIN N/A
- P/E Ratio
- CMPS N/A
- MIN $33.38
- Revenue Growth
- CMPS N/A
- MIN N/A
- 52 Week Low
- CMPS $2.25
- MIN $2.52
- 52 Week High
- CMPS $8.54
- MIN $2.88
- Technical
- Relative Strength Index (RSI)
- CMPS 29.61
- MIN 50.16
- Support Level
- CMPS $2.25
- MIN $2.66
- Resistance Level
- CMPS $5.15
- MIN $2.69
- Average True Range (ATR)
- CMPS 0.40
- MIN 0.02
- MACD
- CMPS -0.27
- MIN -0.00
- Stochastic Oscillator
- CMPS 9.83
- MIN 50.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.